Breast cancer in a male with ankylosing spondylitis treated with TNF-alpha antagonists
Mansouri LE et al. - A 72-year-old male with a 4-year history of TNF-alpha antagonist therapy (infliximab and etanercept) for ankylosing spondylitis was diagnosed with breast cancer. He had a family history of breast cancer. The low incidence and considerable severity of breast cancer in males, genetic risk factors, and potential role for TNF-alpha antagonist therapy are discussed. [more...]
|
|
|
